Search Login Register

latanoprost (Xalatan) Summary

Description: structure given in first source; PHXA34 is the 15(R,S) form

Also Known As: Xalatan; PHXA41; Pfizer brand of latanoprost; PhXA34; Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate

Networked: 878 relevant articles (126 outcomes, 252 trials/studies) for this Drug

Key Diseases for which latanoprost is Relevant

  1. Glaucoma : 60 outcomes 102 studies in 429 results
  2. Ocular Hypertension (Glaucoma, Suspect) : 43 outcomes 92 studies in 273 results
  3. Open-Angle Glaucoma (Glaucoma, Open Angle) : 42 outcomes 107 studies in 328 results
  4. Angle-Closure Glaucoma (Glaucoma, Angle Closure) : 6 outcomes 12 studies in 27 results
  5. Low Tension Glaucoma : 5 outcomes 9 studies in 45 results
Show All >>

Drugs Related to latanoprost

  1. Timolol (Blocadren)
  2. bimatoprost (Lumigan)
  3. travoprost (Travatan)
  4. dorzolamide (Trusopt)
  5. brimonidine (Alphagan)
  6. latanoprost (Xalatan)
  7. Pilocarpine (Ocusert)
  8. hydroxide ion
  9. Dinoprost
  10. brinzolamide (Azopt)
Show All >>

Therapies Related to latanoprost

  1. Phacoemulsification
  2. Intraocular Lenses (Intraocular Lens)
  3. Aftercare (After-Treatment)
  4. Iridectomy
  5. Photorefractive Keratectomy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.